 |
| |
| |
| The
Benefits of Friendly Bacteria |
| The following clinical
studies demonstrate the importance of having
optimal digestive health. |
| |
| NutraFlora®
Assists
and Protects the Immune System |
|
|
| NutraFlora®
is a food source for the friendly bacteria, such
as Bifodobacteria and Lactobacillus. The growth of
these bacteria are important to maintain the
proper environment, keeping the unfriendly
bacteria at a decreased level. If the unfriendly
bacteria is at an increased level above normal,
the toxic compounds they produce will also
increase. These toxic compounds have been
implicated with causing cancer. |
| |
| Supporting Abstract 1 |
(Raibaud, 1992, "Bacteria
interactions in the gut, " Probiotics: The
Scientific Basis, Fuller)
These articles cite the phenomenon "where the
indigenous predominant bacteria adhere to the
intestinal walls, creating a barrier effect, which
protects the body against the proliferation of
alimentary bacteria and potentially pathogenic
bacteria." |
| |
| Supporting Abstract 2 |
(Perdigon and Alvarez, 1992, "Probiotics
and the immune state," Probiotics: The
Scientific Basis, Fuller)
There are several studies indicating that
different friendly lactic acid bacteria can be
used for preventive purposes in intestinal
infections as well as protection against other
diseases in which the immune system is involved. |
| |
| Supporting Abstract 3 |
(Goldin and Gorbach, 1992, "Probiotics
for humans, "Probiotics: The Scientific
Basis, Fuller)
When specific friendly lactic acid bacteria are
used in dairy products, it has been shown that
these bacteria can enhance the immune response of
the body. |
| |
| Supporting Abstract 4 |
(Saavedra, Bauman, Onug, Perman and
Yolken, 1994, "Feeding of Bifidobacterium
bifidum and Streptococcus thermophilus to infants
in hospital for prevention of diarrhea and
shedding of rotavirus," The Lancet, Vol. 344,
Oct 15, 1994)
A study conducted on infants aged five to 24
months were given formula supplements of friendly
bacteria of 17 months. Results indicated that
these infants had reduced the incidence of
diarrhea. |
| |
| NutraFlora®
Protects
against E. Coli and Clostridium |
|
|
| Besides friendly bacteria, such as
Bifidobacteria and Lactobacillus, residing in the
gastrointestinal tract, there are unfriendly
bacteria. There are forms of E.coli and
Clostridium which are indigenous to the body.
These friendly and unfriendly bacteria which are
normally in the body need to remain at a normal
balanced level. Besides these indigenous bacteria,
there are forms of pathogenic bacteria such as
E.coli and Clostridium, which when ingested can
cause such problems as diarrhea. NutraFlora®
is
a food source for the friendly bacteria. As these
bacteria grow, they adhere to the intestinal cell
wall, strengthening and protecting the intestine
from overgrowth of unfriendly bacteria. |
| |
| Supporting Abstract 1 |
(Homma, 1988, "Bifodobacteria
as a Resistance Factor in Human Beings."
Journal article Bifidobacteria Microflora, Vol.
7(1), 35-43)
This article claims Bifidobacteria works as a
resistance factor by adhering more easily to the
intestinal cell wall which protects the body from
strains of E. coli. In a study cited by the
article, subjects who were given friendly bacteria
prior to being given E. coli showed no adverse
effects after introduction of E. coli. |
|
| Supporting Abstract 2 |
(Hidaka, Toshiaki, Takizawa,
Tokunaga, Tashiro, 1986, "Effects of
Fructooligosaccharides on Intestinal Flora and
Human Health." Bifidobacteria Microflora, Vol
5(1), 37-50)
This study demonstrated, through the ingestion of NutraFlora®
subsequent
relief of constipation and suppressed production
if intestinal putrefactive substance caused by the
overgrowth of unfriendly bacteria. |
| |
| Supporting Abstract 3 |
(Buddington, Williams, Cehn, and
Witherly, 1996, "Dietary supplement of
neosugar alters the fecal flora and decreases
activities of some reductive enzymes in human
subjects," American Journal of Clinical
Nutrition. 63: 709-716)
In a study where healthy adults were fed NutraFlora®
the
friendly bacteria in the large intestine was
increased and the unfriendly bacteria decreased.
When the NutraFlora®
was
no longer ingested, the level of friendly bacteria
decreased. |
| |
| Supporting Abstract 4 |
(Gibson, 1995, "Dietary
modulation of the human colonic microbiota,
introducing the concept of prebiotics."
Journal of Nutrition, Vol. 125, No. 6, 1401-1412)
This article describes the effect friendly
bacteria has on the environment, In the large
intestine. Friendly bacteria, such as
Bifidobacteria, change the environment, decreasing
the level of the unfriendly bacteria. |
| |
| Supporting Abstract 5 |
(ref. Shoeyenbos, 1979) (Hentges,
1992, "Gut flora and disease
resistance," Probiotics: The Scientific
Basis, Fuller)
This article states that "indigenous
intestinal bacteria provides protection against
the colonization of pathogenic bacteria",
thus causing a type of barrier effect. |
| |
| Supporting Abstract 6 |
(Alm, 1983, "The effect of
Lactobacillus acidophilus administration upon the
survival of Salmonella in randomly selected human
carriers, Progress in food and Nutrition Science,
7: 13-17)
A study which friendly bacteria was ingested (probiotic),
reduced the effects of having problems with
Salmonella poisoning. |
| |
| Friendly
Bacteria Promote Improved Health |
| |
|
NutraFlora®
is
a food source for the friendly bacteria which in
turn produce compounds called short chain fatty
acids (SCFAs) |
| |
| Supporting Abstract 1 |
(May, T., Mackie R.I., Fahey G.C.
Jr., Cremin J.C., and Garleb, K.A. "Effect of
Fiber Source on Short Chain Fatty Acid Production
and the Growth and Toxin Production by Clostridium
difficile" 1990. Dept. of Animal Science and
Division of Nutritional Sciences University of
Illinois, Seand J. Gastroenterol 1994 19: 916-922)
In a study using NutraFlora®
as
a food source for the friendly bacteria,
Bifidobacteria and Lactobacillus were increasing,
thus increasing short chain fatty acids,
contributing to the prevention of growth and toxin
production of Clostridium difficile. |
| |
| Supporting Abstract 2 |
(Royall D., Wolever B.M., and
Jeejeebhoy K.N. "Clinical Significance of
Colonic Fermentation". American Journal of
Gastroenterology, Vol 85, No. 10 1990.)
This article reviews the benefits of short chain
fatty acids including it antibacterial effect on
pathogenic bacteria. |
| |
| Supporting Abstract 3 |
(Sheppach W., "Effects of
short chain fatty acids on gut morphology and
function". Gut 1994: Supplement 1.535-538)
This article cites different studies about short
chain fatty acids in which they have been shown to
act as an anti-diarrheal agent and promote
intestinal cell proliferation. |
|
| Supporting Abstract 4 |
(Mortenson per Borbech and Mette
Rye Clausen. "Antibiotic-associated
diarrhea" Falk symposium, 1993, Short Chain
Fatty Acids, France, Chapter 21, 240-247)
In this study patients five antibiotics had an
imbalance of the friendly and unfriendly bacteria,
resulting in a reduction in short chain fatty
acids. |
|
| Supporting Abstract 5 |
(Young, Graeme, and Peter Gibson.
"Butyrate and the Colorectal Cancer
Cell". Falk Symposium, 1993, Short Chain
Fatty Acids, France Chapter 13, 148-160)
This article suggests the possibility of a short
chain fatty acid, butyrate, may genetically or
functionally suppress the potential growth of
colorectal tumors. |
| |
|
|
|
|
| |
|
As always, consult your
physician before you begin any new supplement, including
NutraFlora®. The above statements have not been evaluated
by the Food and Drug Administration. NutraFlora® is not
intended to diagnose, treat, cure, or prevent any disease. |
|
|
|
